Oligonucleotide Synthesis Supports the Rapid Development of Nucleic Acid Drugs
As the commercialization of nucleic acid drugs continues to advance, oligonucleotide synthesis technology will continue to play a key role in future biomedical innovation
2026-02-02
Peptide Synthesis Provides Stable Support for Peptide Drug Development
In the trend of continuously increasing peptide drug research and development, a mature and reliable peptide synthesis service platform is becoming an important guarantee for project success
2026-01-26
Drug Conjugates Technology Drives Continuous Upgrades in Precision Medicine
As technology platforms gradually mature, Drug Conjugates are expected to achieve broader applications in oncology, autoimmune diseases, and other complex diseases, becoming an important component of the precision medicine system
2026-01-19
How Do Small Molecule APIs Support Continuous Innovation in the Pharmaceutical Industry
With the continuous advancement of innovative drugs and high-end generic drugs, Small Molecule APIs are upgrading from traditional manufacturing to high-tech, high-value-added production
2026-01-12
Drug Product DP Platforms Enable Integrated Solutions from Raw Materials to Finished Drugs
Mature Drug Product DP Platforms can support multiple stages, including formulation development, process scale-up, clinical sample preparation, and commercial production
2026-01-05
CDMO for Biologics: Empowering the Full Lifecycle Development of Biopharmaceuticals
With the rapid evolution of biopharmaceutical technology, CDMO for Biologics is becoming an indispensable strategic cooperation model for innovative pharmaceutical companies
2025-12-29
Partners with stable GMP peptide manufacturing capabilities are becoming a crucial support force for international pharmaceutical companies in advancing peptide drug development
2025-12-22
Peptide API Manufacturing: Building Industrialization Capabilities for High-Quality Peptide APIs
Through continuous process optimization and quality management system development, advanced Peptide API Manufacturing capabilities are providing reliable support to global pharmaceutical companies
2025-12-15
GMP Peptides: The Core Standard for Ensuring the Quality of Peptide Drugs
In peptide drug production, GMP certification is the cornerstone of ensuring drug quality. By adhering to GMP standards, pharmaceutical companies can ensure the reliability of their peptide drugs in terms of quality
2025-12-10
Understanding Small Molecule Drug Manufacturing: Mastering the Future of Drug Production
Small molecule drug manufacturing is a complex and challenging process, but partnering with a professional CDMO can improve production efficiency, guarantee drug quality, and ensure that products can enter the market quickly and safely
2025-12-03
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
